Abstract
We outlined five studies regarding the quality of the review by committees based on the Act on the Safety of Regenerative Medicine. The findings raise serious concerns about the independence, integrity, and quality of reviews of therapeutic plans by these committees with inappropriately close relationships to medical institutions and companies.
| Original language | English |
|---|---|
| Pages (from-to) | 613-617 |
| Number of pages | 5 |
| Journal | Stem cell reports |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2023 Mar 14 |
ASJC Scopus subject areas
- Biochemistry
- Genetics
- Developmental Biology
- Cell Biology